Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
10 Brooks, M
10.2337/db24-0861 129 SharmaS.MellsJ
AOD-9604 has been studied extensively in both preclinical animal models and human clinical trials involving approximately 900 participants
It maps pathway-level variants in MC4R, FTO, GLP1R, and TCF7L2 that describe your baseline metabolic biology, so the money you spend follows an informed picture rather than a number chosen without any biological context behind it
Research Context Multi-peptide blends at elevated doses are studied for several distinct research purposes: Dose-response research Higher-concentration blends allow researchers to construct dose-response curves across a wider concentration range within the same compound supply Extended protocol studies A single high-dose vial reduces reconstitution frequency in longitudinal research protocols requiring consistent compound ratios over extended timeframes Multi-pathway synergy investigation The inclusion of BPC-157, TB-500, and additional compounds allows researchers to study potential interactions across multiple repair and regenerative signalling pathways simultaneously Comparative dosing studies Comparing outcomes between standard-dose individual compounds (e.g., BPC-157 + TB-500 20mg) and higher-concentration blends in matched tissue models Product Specifications Key Questions How does KLOW differ from the BPC-157 + TB-500 blend
US$ 20.06
US$ 27.45
US$ 29.94
US$ 27.01
US$ 25.44
US$ 21.49
US$ 21.73
US$ 22.80
US$ 22.28
